DE000HG5V4M3/ DE000HG5V4M3 /
26/06/2024 21:35:38 | Diferencia-0.060 | Bid21:59:31 | Ask21:59:31 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
3.050EUR | -1.93% | 3.040 Volumen de oferta: 50,000 |
3.060 Tamaño/ Volumen/ Formato de Ask: 50,000 |
NIKE INC. B | 61.6845 - | 31/12/2078 | Call |
GlobeNewswire
23:30
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esoph...
GlobeNewswire
23:30
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic e...
GlobeNewswire
23:00
CenterPoint Energy, Inc. to Host Webcast of Second Quarter 2024 Earnings Conference Call
GlobeNewswire
23:00
ROHM Develops a Novel VCSELED™ Infrared Light Source that Combines Features of VCSELs and LEDs
GlobeNewswire
22:53
OV Entertainment Group Acquires Brazilian Studio Kokku Games and Argentinian Studio 3OGS
GlobeNewswire
22:41
Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials La...
GlobeNewswire
22:39
NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página